DIABETES PATIENT ADVOCACY COALITION for DIABETES PATIENT ADVOCACY COALITION
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM, Docket No. FDA-2016-N-0400 FDA LANCET DEVICES GUIDANCE DOCKET, Docket No. FDA-2016-N-0001 FDA DIABETES DEXCOM G5 LABELING CHANGE
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTEL MARCHAND APRIGLIANO | — |
| BENNET DUNLAP | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.